UltraPlasma™ Hyperhidrosis Treatments
withOut! Drugs, Industrial Chemicals, Medicines, Surgery, Supplements, and Lasers.
TREATMENTS*
MedicaLabs, Germany | https://medicalabs.de
10/24/20242 min read


UltraPlasma™ Multi-Platform Plasma Systems for Hyperhidrosis Treatment
Abstract
Hyperhidrosis, or excessive sweating, is a challenging dermatological condition with physical and social impacts. UltraPlasma™ introduces an advanced treatment approach utilizing multi-platform plasma technologies—arc, argon, and helium—merged under a single precision-controlled hardware and software ecosystem. This article explores the therapeutic mechanism, biological gas generation (O₃, NO, O), skin and blood interactions across all skin layers, and outlines how this platform revolutionizes hyperhidrosis therapy.


1. Introduction to Hyperhidrosis and Challenges
Hyperhidrosis affects millions globally and often resists conventional treatments such as antiperspirants, iontophoresis, or botulinum toxin injections. The need for non-invasive, effective, and regenerative options has led to the development of plasma-assisted modalities.
UltraPlasma™ addresses this unmet need with its triple plasma system, combining:
UltraPlasma™ Arc Plasma Mode (High penetration, high intensity)
UltraPlasma™ Argon Plasma Mode (Ionized noble gas, controlled reactivity)
UltraPlasma™ Helium Plasma Mode (Gentle, deep diffusion and selective excitation).


2. UltraPlasma™ System Architecture
2.1. UltraPlasma™ Software-Hardware Synergy
Precision Pulse Control: Modulates voltage-frequency and waveform specific to gas species.
Gas Switching & Mixing: Dynamically shifts between or blends arc, argon, and helium.
Sensor Feedback Loop: Monitors skin impedance, moisture, and temperature to ensure safety and optimal efficacy.
2.2. UltraPlasma™ Output Spectrum


3. Biological Interactions
3.1. UltraPlasma™ Epidermal-Dermal Effects
Protein Coagulation in Sweat Glands
Temporary blockage of eccrine glands
Antimicrobial and anti-inflammatory activity
3.2. UltraPlasma™ Hypodermal and Blood Modulation
The hypodermis layer and capillary microcirculation are influenced via:
Nitric Oxide (NO): Enhances vasodilation, modulates gland activity.
Ozone (O₃): Disinfects and oxidizes volatile organic sweat components.
Singlet Oxygen (¹O₂) & Reactive Species: Stabilizes skin pH and glandular balance.
3.3. UltraPlasma™ Controlled Gas Emissions


4. Clinical Protocol
Session Setup:
Duration: 4–7 minutes per axilla or palmar/plantar zone
Plasma Mix: Arc + Helium blend for deep control
Mode: Pulsed waves (bursts at 30 Hz)
Weekly Schedule:


5. Advantages Over Traditional Treatments


⌘Conclusion⌘
UltraPlasma™ represents a next-generation tool in managing hyperhidrosis by intelligently merging multiple plasma types under digital control. Through precise modulation of plasma species and real-time skin interaction feedback, the treatment enables permanent or semi-permanent sweat reduction while enhancing skin health and vascular functionality.
Shortcuts for our Goals!
▼


© 2025. All rights reserved.
MedicaLabs Deutschland
medicalabs.de


worldwide ultraplasma.com
countries locally - coming soon:
ultraplasma.de | ultraplasma.us | ultraplasma.cn | ultraplasma.uk | ultraplasma.it | ultraplasma.fr | ultraplasma.tr | ultraplasma.co.il | ultraplasma.az | ultraplasma.ru | ultraplasma.kr | ultraplasma.es | ultraplasma.in | ultraplasma.gr | ultraplasma.cz | ultraplasma.se | ultraplasma.cl | ultraplasma.rs | ultraplasma.sg | ultraplasma.qa | ultraplasma.nl | ultraplasma.dk | ultraplasma.ro | ultraplasma.fi | ultraplasma.co.za | ultraplasma.pt | ultraplasma.al | ultraplasma.pk | ultraplasma.si | ultraplasma.ch | ultraplasma.at | ultraplasma.lt | ultraplasma.nz | ultraplasma.ae | ultraplasma.hu | ultraplasma.pl | ultraplasma.be | ultraplasma.am | ultraplasma.ar |